Department of Dermatology, Taipei City Hospital, Renai Branch, Taipei, Taiwan; Center for General Education, Mackay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan;
Institute of Clinical Research and Training, Taipei City Hospital, Taipei, Taiwan and Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Pediatrics. 2015 Mar;135(3):e565-71. doi: 10.1542/peds.2013-4037.
There are limited population-based data regarding pediatric herpes zoster (HZ).
Children aged <12 years with varicella infections between 2000 and 2006 were identified from a national population-based database and followed-up for a diagnosis of HZ until December 2008. Since a routine varicella vaccination program was started in 2004, vaccinated children without medically attended varicella were identified between 2004 and 2006, and followed-up for a diagnosis of HZ until December 2008.
Of 27 517 children with medically attended varicella, 428 developed HZ. The incidence of HZ was 262.1 per 100 000 person-years. Of 25 132 vaccinated children without medically attended varicella, 106 developed HZ. The incidence of HZ was 93.3 per 100 000 person-years. The mean duration from varicella to HZ was 4.12 years. Children diagnosed with varicella at aged <2 years had a higher incidence (P < .001) and shorter duration (P = .04) than those diagnosed aged ≧2 years. Children diagnosed with varicella aged ≥2 but <8 years had a significantly increased incidence of HZ after than before the vaccination program (relative risk = 1.85 at 3 years of follow-up, P = .03). Children with varicella infections had a significantly greater risk of HZ than vaccinated children without a history of varicella (relative risk = 2.31 at 4 years of follow-up, P < .001).
This study demonstrates the population-based epidemiologic characteristics of pediatric HZ among those who contracted varicella. In the early postvaricella vaccination period, an increased HZ incidence was observed among children with varicella infection aged ≥2 years.
关于儿童带状疱疹(HZ),目前仅有有限的基于人群的数据。
从全国人群数据库中确定了 2000 年至 2006 年患有水痘感染的年龄<12 岁的儿童,并随访至 2008 年 12 月,以诊断 HZ。由于 2004 年开始常规进行水痘疫苗接种,因此在 2004 年至 2006 年期间,确定了未因水痘就医的接种儿童,并随访至 2008 年 12 月,以诊断 HZ。
在 27517 名因水痘就医的儿童中,有 428 名发生 HZ。HZ 的发病率为每 100000 人年 262.1 例。在 25132 名未因水痘就医的接种儿童中,有 106 名发生 HZ。HZ 的发病率为每 100000 人年 93.3 例。从水痘到 HZ 的平均时间为 4.12 年。年龄<2 岁诊断为水痘的儿童发病率较高(P<.001),且时间间隔较短(P=0.04)。年龄≥2 岁但<8 岁的儿童在疫苗接种计划后比之前 HZ 的发病率显著增加(3 年随访时的相对风险=1.85,P=0.03)。水痘感染的儿童发生 HZ 的风险显著高于无水痘史的接种儿童(4 年随访时的相对风险=2.31,P<.001)。
本研究表明了水痘感染儿童中 HZ 的基于人群的流行病学特征。在水痘疫苗接种后的早期,年龄≥2 岁的水痘感染儿童的 HZ 发病率增加。